Serotonergic mechanisms of regulation of the systemic circulation vessels lumen
- Authors: Sveshnikov DS1, Kuchuk AV1, Smirnov VM2, Cherepanova GV1
-
Affiliations:
- Medical Institute of Peoples’ Friendship University of Russia
- Russian National Research Medical University
- Issue: Vol 97, No 1 (2016)
- Pages: 89-94
- Section: Reviews
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/2372
- DOI: https://doi.org/10.17750/KMJ2016-89
- ID: 2372
Cite item
Full Text
Abstract
Keywords
About the authors
D S Sveshnikov
Medical Institute of Peoples’ Friendship University of Russia
Author for correspondence.
Email: dmsveshnikov@gmail.com
A V Kuchuk
Medical Institute of Peoples’ Friendship University of Russia
Email: dmsveshnikov@gmail.com
V M Smirnov
Russian National Research Medical University
Email: dmsveshnikov@gmail.com
G V Cherepanova
Medical Institute of Peoples’ Friendship University of Russia
Email: dmsveshnikov@gmail.com
References
- Ахметзянов В.Ф., Латфуллин И.А., Нигматуллина Р.Р. Современные представления о роли серотонинергической системы в регуляции сердечно-сосудистой деятельности в норме и патологии. Казанский мед. ж. 2006; 87 (2): 110-121.
- Нигматуллина Р.Р., Кириллова В.В., Джорджикия Р.К. и др. Концентрация серотонина в крови и тромбоцитах у пациентов с ХСН. Ж. сердечн. недостат. 2008; 9 (6): 289-291.
- Свешников Д.С., Смирнов В.М., Мясников И.Л., Кучук А.В. Исследование природы нервных волокон симпатического ствола, вызывающих усиление сокращений желудка. Бюлл. эксперим. биол. и мед. 2011; 152 (9): 249-252.
- Свешников Д.С., Торшин В.И., Смирнов В.М. и др. Значение различных серотониновых рецепторов в регуляции моторики желудочно-кишечного тракта. Патол. физиол. и эксперим. терап. 2014; (3): 45-51.
- Barnes N., Andrade R., Bockaert J. et al. 5-Hydroxytryptamine receptors, introduction. IUPHAR/BPS Guide to Pharmacology. Last modified on 19/11/2014. http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=1 (access date: 12.06.2015).
- Bhaskaran S., Zaluski J., Banes-Berceli A. Molecular interactions of serotonin (5-HT) and endothelin-1 in vascular smooth muscle cells: in vitro and ex vivo analyses. Am. J. Physiol. Cell Physiol. 2014; 306 (2): 143-151. http://dx.doi.org/10.1152/ajpcell.00247.2013
- Brenner B., Harney J.T., Ahmed B.A. et al. Plasma serotonin levels and the platelet serotonin transporter. J. Neurochem. 2007; (102): 206-215. http://dx.doi.org/10.1111/j.1471-4159.2007.04542.x
- Centurion D., Glusa E., Sanchez-Lopez A. et al. 5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathetctomized rats. Eur. J. Pharmacol. 2004; (502): 239-242. http://dx.doi.org/10.1016/j.ejphar.2004.08.050
- Cohen M.L., Fuller R.W., Kurz K.D. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. J. Pharmacol. Exp. Ther. 1983; (227): 327-332.
- Dalton D.W., Feniuk W., Humphrey P.P. An investigation into the mechanisms of the cardiovascular effects of 5-hydroxytryptamine in conscious normotensive and DOCA-salt hypertensive rats. J. Auton. Pharmacol. 1996; (6): 219-228.
- Darios E.S., Barman S.M., Orer H.S. et al. 5-Hydroxytryptamine does not reduce sympathetic nerve activity or neuroeffector function in the splanchnic circulation. Eur. J. Pharmacol. 2015; (5): 140-147. http://dx.doi.org/10.1016/j.ejphar.2015.02.032
- Diaz J., Ni W., King A. et al. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. J. Pharmacol. Exp. Ther. 2008; (325): 1031-1038. http://dx.doi.org/10.1124/jpet.108.136226
- Dong J.S., Hyun J.N., Jae G.K. et al. Serotonin contracts the rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels via the 5-HT2A receptor and Src tyrosine kinase. Experim. Mol. Med. 2013; (45): 1-10.
- Dorn S.D., Morris C.B., Hu Y. Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J. Clin. Gastroenterol. 2009; (43): 214-220. http://dx.doi.org/10.1097/MCG.0b013e31815bd749
- Gaddum J.H., Picarelli Z.P. Two kinds of tryptamine receptor. Br. J. Pharmacol. 1957; (12): 323-328. http://dx.doi.org/10.1111/j.1476-5381.1957.tb00142.x
- Gershon M.D. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr. Opin. Endocrinol. Diabetes Obes. 2013; 20 (1): 14-21. http://dx.doi.org/10.1097/MED.0b013e32835bc703
- Gershon M.D., Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007; 132 (1): 397-414. http://dx.doi.org/10.1053/j.gastro.2006.11.002
- Gothert M., Molderings G.J., Fink K., Schlicker E. Heterogeneity of presynaptic serotonin receptors on sympathetic neurons in blood vessels. Blood Vessels. 1991; (28): 11-18.
- Gradin K., Pettersson A., Hedner T., Persson B. Chronic 5-HT2 receptor blockade with ritanserin does not reduce blood pressure in the spontaneously hypertensive rat. J. Neural. Transm. 1985; (64): 145-149. http://dx.doi.org/10.1007/BF01245975
- Kawasaki H., Takasaki K. Vasoconstrictor response induced by 5-hydroxytryptamine released from vascular adrenergic nerves by periarterial nerve stimulation. J. Pharmacol. Exp. Ther. 1984; (229): 816-822. http://dx.doi.org/10.1111/j.1440-1681.2011.05504.x
- Linder A.E., Davis R.P., Burnett R., Watts S. Function of the serotonin transporter in vasculature of the female rat: comparison with the male. Clin. Exp. Pharmacol. Physiol. 2011; 38 (5): 314-322.
- Machida T., Iizuka K., Hirafuji M. Recent advances in 5-hydroxytryptamine (5-HT) receptor research: how many pathophysiological roles does 5-HT play via its multiple receptor subtypes? Biol. Pharm. Bull. 2013; 36 (9): 1416-1419. http://dx.doi.org/10.1248/bpb.b13-00344
- Moreno L., Martinez-Cuesta M.A., Pique J.M. et. al. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats. Naunyn Schmiedebergs Arch. Pharmacol. 1996; (354): 474-480. http://dx.doi.org/10.1007/BF00168439
- Ni W., Geddes T.J., Priestley J.R. et al. The existence of a local 5-hydroxytryptaminergic system in peripheral arteries. Br. J. Pharmacol. 2008; (154): 663-674. http://dx.doi.org/10.1038/bjp.2008.111
- Ni W., Thompson J., Northcott C. et al. The serotonin transporter is present and functional in peripheral arterial smooth muscle. J. Cardiovasc. Pharmacol. 2004; (43): 770-781. http://dx.doi.org/10.1097/00005344-200406000-00006
- Russell A., Banes A., Berlin H. et al. 5-Hydroxytryptamine 2B receptor function is enhanced in the N-nitro-L-arginine hypertensive rat. J. Pharmacol. Exp. Ther. 2002; (303): 179-187. http://dx.doi.org/10.1124/jpet.102.037390
- Terron J.A., Sanchez-Maldonado C., Martinez-Garcia E. Pharmacological evidence that 5-HT1B/1D receptors mediate hypotension in anesthetized rats. Eur. J. Pharmacol. 2007; (576): 132-135. http://dx.doi.org/10.1016/j.ejphar.2007.08.005
- Van Zwieten P.A., Blauw G.F., van Brummelen P. Serotonergic receptors and drugs in hypertension. Pharmacol. Toxicol. 1992; (70): 17-22. http://dx.doi.org/10.1111/j.1600-0773.1992.tb01617.x
- Watts S.W., Davis R.P. 5-Hydroxtryptamine receptors in systemic hypertension: an arterial focus. Cardiovasc. Ther. 2011; 29 (1): 54-67. http://dx.doi.org/10.1111/j.1755-5922.2010.00173.x
- Watts S.W., Darios E.S., Seitz B.M., Thompson J.M. 5-HT is a potent relaxant in rat superior mesenteric veins. Pharmacol. Res. Perspect. 2015; 3 (1): e00103. doi: 10.1002/ prp2.103. Epub 2015 Jan. 5.
- Watts S.W., Baez M., Webb R.C. The 5-hydroxytryptamine 2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertension. J. Pharmacol. Exp. Ther. 1996; (277): 1103-1113.
- Wouters M.M., Farrugia G., Schemann M. 5-HT receptors on interstitial cells of Cajal, smooth muscle and enteric nerves. Neurogastroenterol. Motil. 2007; 19 (2): 5-12. http://dx.doi.org/10.1111/j.1365-2982.2007.00963.x